Papers
1
Total Citations
20
H-Index
1
About
Xiangshu Li is a pioneering surgeon-scientist at the forefront of robotic colorectal surgery, whose work is reshaping the landscape of minimally invasive oncology. His research centers on the comparative effectiveness of robotic surgical systems, with a particular focus on advancing accessible, high-quality surgical technology. Li’s most notable contribution is his leadership of a multicentre randomised controlled noninferiority trial comparing the KangDuo surgical robot—a domestically developed system—against the established da Vinci Xi platform for radical resection of colorectal cancer. This landmark 2024 study, already garnering 20 citations, demonstrated that the KangDuo robot achieves short-term outcomes comparable to the global gold standard, offering a cost-effective alternative that could democratize robotic surgery worldwide. By rigorously validating emerging technologies, Li is not only expanding surgical options for patients but also catalyzing innovation in medical robotics. His work bridges engineering and clinical practice, providing critical evidence that can guide healthcare policy and surgical training. For students and researchers, Li exemplifies how methodical clinical trials can drive technological adoption, making advanced care more equitable.
Research Focus
Key Achievements
Top Papers
- 1